Gainers
-
AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) rose
55.3 percent to $1.130 in pre-market trading after the company reported positive CHMP opinion for tivozanib for the treatment
of advanced renal cell carcinoma.
-
Synchronoss Technologies, Inc. (NASDAQ: SNCR)
gained 38.4 percent to $16.86. Siris Capital believes it is in a position to buy Synchronoss at $18 per share in cash.
-
Cara Therapeutics Inc (NASDAQ: CARA) rose 8.2
percent to $21.50 in pre-market trading after the company disclosed that it has received Breakthrough Therapy designation for
IV CR845 for the treatment of chronic kidney disease-associated pruritus in hemodialysis patients.
-
Bellicum Pharmaceuticals Inc (NASDAQ: BLCM) rose
6.9 percent to $14.94 in pre-market trading after surging 10.51 percent on Thursday.
-
Line Corp (ADR) (NYSE: LN) rose 6.1 percent to $38.33
in pre-market trading after falling 0.58 percent on Thursday.
-
Yingli Green Energy Holding Co Ltd (ADR) (NYSE: YGE)
rose 6 percent to $2.31 in pre-market trading after gaining 5.31 percent on Thursday.
-
LG Display Co Ltd. (ADR) (NYSE: LPL) rose 5.1
percent to $16.95 in pre-market trading after gaining 0.12 percent on Thursday.
-
Sohu.com Inc (NASDAQ: SOHU) shares rose 4.9
percent to $47.82 in pre-market trading after falling 1.62 percent on Thursday.
-
NRG Energy Inc (NYSE: NRG) shares rose 4.9 percent
to $18.07 in pre-market trading after gaining 2.68 percent on Thursday.
-
Applied Genetic Technologies Corp (NASDAQ: AGTC)
rose 4.5 percent to $5.80 in pre-market trading after declining 1.77 percent on Thursday.
-
AK Steel Holding Corporation (NYSE: AKS) shares rose
3.5 percent to $6.52 in the pre-market trading session. Deutsche Bank upgraded AK Steel from Hold to Buy.
-
Yamana Gold Inc. (USA) (NYSE: AUY) shares rose 3.2
percent to $2.60 in pre-market trading after surging 3.70 percent on Thursday.
-
United States Steel Corporation (NYSE: X) shares rose
2.7 percent to $21.64 in pre-market trading. Deutsche Bank upgraded United States Steel from Hold to Buy.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Losers
-
Bed Bath & Beyond Inc. (NASDAQ: BBBY) shares fell
9 percent to $30.70 in pre-market trading after the company reported weaker-than-expected results for its first quarter.
-
BlackBerry Ltd (NASDAQ: BBRY) shares fell 6.2
percent to $10.37. BlackBerry reported better-than-expected earnings for its third quarter, while revenue missed expectations.
-
Ocular Therapeutix Inc (NASDAQ: OCUL) fell 5.4
percent to $10.92 in pre-market trading. Ocular Therapeutix disclosed that Antony Mattessich will succeed Dr. Amar Sawhney as
CEO of the company. Morgan Stanley downgraded Ocular Therapeutix from Overweight to Equal-Weight.
-
bluebird bio Inc (NASDAQ: BLUE) shares fell 5.1
percent to $112.50 in pre-market trading after the company issued new data from HGB-205 study of LentiGlobin drug product.
-
Hain Celestial Group Inc (NASDAQ: HAIN) shares
fell 2.5 percent to $31.86 in pre-market trading. JP Morgan downgraded Hain Celestial from Overweight to Neutral.
-
JinkoSolar Holding Co., Ltd. (NYSE: JKS) fell 2.2
percent to $19.81 in pre-market trading after rising 4.43 percent on Thursday.
-
Finish Line Inc (NASDAQ: FINL) fell 2 percent to
$12.50 in pre-market trading. Finish Line reported in-line earnings for its first quarter, while sales missed estimates.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.